Article
The effect of an individualized GnRH antagonist protocol on folliculogenesis in IVF/ICSI
3 Jun 2004
Abstract excerpt
BACKGROUND: The aim of this study was to assess the effect of an individualized GnRH antagonist regimen on folliculogenesis. METHODS: In a multicentre, randomized, clinical trial, IVF/ICSI patients were allocated to a standard regimen, in which they received daily 0.25 mg GnRH antagonist ganirelix (Orgalutran) from the 6th day of stimulation onward (fixed regimen n = 102) or to an individualized regimen, in which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
